CID 86574712

5'-ccgtcaccgg-3'

Structural Information

Molecular Formula
C95H123N37O61P10
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)O)N6C=CC(=NC6=O)N)N7C=CC(=NC7=O)N)N8C=NC9=C8N=C(NC9=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C95H123N37O61P10/c1-38-22-128(95(143)122-83(38)134)70-18-45(55(181-70)29-171-203(163,164)193-48-21-73(132-37-110-77-82(132)118-89(104)121-86(77)137)184-58(48)32-174-200(157,158)188-42-15-67(125-9-4-61(98)113-92(125)140)177-51(42)25-167-196(149,150)185-40-13-65(123-7-2-59(96)111-90(123)138)176-50(40)24-165-194(144,145)146)190-201(159,160)169-27-53-44(17-69(179-53)127-11-6-63(100)115-94(127)142)187-198(153,154)172-30-56-46(19-71(182-56)129-34-107-74-78(101)105-33-106-79(74)129)192-202(161,162)170-28-54-41(14-66(180-54)124-8-3-60(97)112-91(124)139)186-197(151,152)168-26-52-43(16-68(178-52)126-10-5-62(99)114-93(126)141)189-199(155,156)173-31-57-47(20-72(183-57)131-36-109-76-81(131)117-88(103)120-85(76)136)191-195(147,148)166-23-49-39(133)12-64(175-49)130-35-108-75-80(130)116-87(102)119-84(75)135/h2-11,22,33-37,39-58,64-73,133H,12-21,23-32H2,1H3,(H,147,148)(H,149,150)(H,151,152)(H,153,154)(H,155,156)(H,157,158)(H,159,160)(H,161,162)(H,163,164)(H2,96,111,138)(H2,97,112,139)(H2,98,113,140)(H2,99,114,141)(H2,100,115,142)(H2,101,105,106)(H,122,134,143)(H2,144,145,146)(H3,102,116,119,135)(H3,103,117,120,136)(H3,104,118,121,137)
InChIKey
UJKCUBPRUKAFRR-UHFFFAOYSA-N
Compound name
[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(4-amino-2-oxopyrimidin-1-yl)-2-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3067.5037 Da
Monoisotopic Mass

-22.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3068.5110 284.1
[M+Na]+ 3090.4929 288.3
[M-H]- 3066.4964 285.4
[M+NH4]+ 3085.5375 285.7
[M+K]+ 3106.4669 286.1
[M+H-H2O]+ 3050.5010 283.5
[M+HCOO]- 3112.5019 286.0
[M+CH3COO]- 3126.5176 286.6
[M+Na-2H]- 3088.4784 292.7
[M]+ 3067.5032 285.2
[M]- 3067.5042 285.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.